Form 8-K - Current report:
SEC Accession No. 0000059478-22-000117
Filing Date
2022-04-14
Accepted
2022-04-14 16:57:23
Documents
13
Period of Report
2022-04-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K lly-20220414.htm   iXBRL 8-K 43508
  Complete submission text file 0000059478-22-000117.txt   207331

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20220414.xsd EX-101.SCH 2149
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20220414_def.xml EX-101.DEF 14383
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20220414_lab.xml EX-101.LAB 27642
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20220414_pre.xml EX-101.PRE 14943
7 EXTRACTED XBRL INSTANCE DOCUMENT lly-20220414_htm.xml XML 10923
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 22828003
SIC: 2834 Pharmaceutical Preparations